Methodological Considerations for the High Sensitivity Detection of Multiple Myeloma Measurable Residual Disease

BACKGROUND: Recent advances in therapeutic interventions have dramatically improved complete response rates in patients with multiple myeloma (MM). The ability to identify residual myeloma cells (e.g. measurable residual disease (MRD)) can provide valuable information pertaining to patient’s depth o...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cytometry B Clin Cytom
Asıl Yazarlar: Soh, Kah Teong, Tario, Joseph D., Hahn, Theresa, Hillengass, Jens, McCarthy, Philip L., Wallace, Paul K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7741435/
https://ncbi.nlm.nih.gov/pubmed/31868315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cyto.b.21862
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller